How Principal Investigators Can Proactively Improve Patient Enrollment
Failure to enroll enough patients is one of the primary reasons clinical trials fail. Direct mail, advertising and social media…
Moving From Health Disparity to Health Equity: Addressing Social Determinants of Health to Improve CKD Outcomes
Socioeconomic status influences chronic kidney disease (CKD) risk. Socioeconomic disparities intertwine with racial, geographic and health care disparities. One result:…
Activating Clinical Trial Sites Quickly During COVID-19 Lockdowns
A sponsor needed to enroll at least 200 patients for a pivotal Phase IIIb clinical trial — right when the…
By the Numbers: Optimize Sites for Your Nephrology-Related Trials With Frenova
See how Frenova’s impact on CKD and ESRD clinical trials compares to industry averages. The numbers don’t lie: our clinical…
The Funding Disparity in Clinical Trials for CKD: Why What You See Is Not What You Get
Chronic kidney disease (CKD) is a public health crisis impacting 13.4% of the global population and is a leading cause…
Access to Patients = Exceeded Enrollment
See how Frenova’s clinical research sites, through rapid startup, leveraged relationships and site management achieved enrollment goals in less time…
Frenova Helps With Business, Allows Principal Investigator to Focus on Care
Clinical investigators regularly report that logistical barriers hinder their conduct of clinical trials. Physician and staff workload balance, the time…
Changing Ways: Patient Participation
For many patients across a wide range of therapeutic areas, participation in a clinical trial can provide access to important…
Clinical Research 101: Participating in a Trial
Clinical research is vital to find ways to improve quality of life, find cures and identify better treatments for kidney…
Clinical Research 101: Participating in a Trial
Clinical research is vital to find ways to improve quality of life, find cures and identify better treatments for kidney…